1. Home
  2. MAA vs RLAY Comparison

MAA vs RLAY Comparison

Compare MAA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

HOLD

Current Price

$134.02

Market Cap

15.8B

Sector

Real Estate

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$10.24

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAA
RLAY
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MAA
RLAY
Price
$134.02
$10.24
Analyst Decision
Buy
Strong Buy
Analyst Count
19
8
Target Price
$152.95
$15.75
AVG Volume (30 Days)
984.3K
1.8M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
4.50%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
$2.85
$19.96
Revenue Next Year
$3.30
N/A
P/E Ratio
$35.71
N/A
Revenue Growth
N/A
53.44
52 Week Low
$125.75
$1.78
52 Week High
$173.38
$9.54

Technical Indicators

Market Signals
Indicator
MAA
RLAY
Relative Strength Index (RSI) 48.81 69.98
Support Level $130.50 $2.99
Resistance Level $136.83 N/A
Average True Range (ATR) 2.75 0.66
MACD 0.08 0.08
Stochastic Oscillator 41.34 62.92

Price Performance

Historical Comparison
MAA
RLAY

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: